Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
primary immunodeficiency diseases/carbohydrate
Länken sparas på Urklipp
11 resultat
Method for the detection of human immunodeficiency virus envelope (HIV) glycoprotein utilizing carbohydrate binding module (CBM) 20 or 21
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention relates to an antibody mimetic of carbohydrate binding module (CBM) which specifically binds to an epitope on HIV glycoprotein. The present invention also relates to a method of detecting HIV glycoprotein.
BACKGROUND OF THE INVENTION
Human
Carbohydrate-lipid constructs and their use in preventing or treating viral infection
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase of International Application No. PCT/NZ2008/000095 filed 28 Apr. 2008 which designated the U.S. and claims priority to 554853 filed 27 Apr. 2007; 556736 filed 24 Jul. 2007, and 567754 filed 24 Apr. 2008, the entire
Carbohydrate-lipid constructs and their use in preventing or treating viral infection
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention relates to selected carbohydrate-lipid constructs and their use as mimics of ligands for receptors expressed by a virus.
In particular, the invention relates to the use of selected carbohydrate-lipid constructs in methods of inhibiting viral infection and/or promoting
Antiviral therapies
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Stage of International Application No. PCT/BE2006/000104, filed Sep. 21, 2006, which claims the benefit of British Patent Application No. 0519169.7, filed Sep. 21, 2005.
FIELD OF THE INVENTION
The field of the invention
Antiviral therapies
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The field of the invention relates to the use of carbohydrate binding compounds as a medicine, their use to treat or prevent viral infections, their use to manufacture a medicament to treat or prevent viral infections and their use in a vaccination strategy. The present
Anti-viral azide containing compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Viral infections account for significant morbidity and mortality in humans and animals. In addition, viral infections also result in significant agricultural losses, with plant viruses causing an estimated $60 billion in lost crop yields throughout the world each year. Although
Anti-viral azide containing compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Viral infections account for significant morbidity and mortality in humans and animals. In addition, viral infections also result in significant agricultural losses, with plant viruses causing an estimated $60 billion in lost crop yields throughout the world each year. Although
Anti-viral azide containing compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Viral infections account for significant morbidity and mortality in humans and animals. In addition, viral infections also result in significant agricultural losses, with plant viruses causing an estimated $60 billion in lost crop yields throughout the world each year. Although
Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Viruses infecting humans, animals, plant and insects are well known. Infection of these hosts by viruses can result in disease unless an appropriate immunological response is available to neutralize the infection. Vaccines capable of eliciting the immunological components necessary for an
Anti-viral azide containing compounds
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Viral infections account for significant morbidity and mortality in humans and animals. In addition, viral infections also result in significant agricultural losses, with plant viruses causing an estimated $60 billion in lost crop yields throughout the world each year. Although
Crystals of triazaspiro[5.5]undecane derivative
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This application is a 371 of PCT/JP03/11835 filed Sep. 17, 2003 which claims priority to JAPAN 2002-272079 filed Sep. 18, 2002.
TECHNICAL FIELD
The present invention relates to crystals of (3R)-1-butyl-2,5-dioxo-3-((1R)-1-hydroxy-1-cyclohexylmethyl)-9-(4-(4-carb-
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
